B. Walker

发表

Control of HIV despite the discontinuation of antiretroviral therapy.

J. Lisziewicz, E. Rosenberg, J. Lieberman, 1999, The New England journal of medicine.

HIV type 1-specific helper T cells: a critical host defense.

E. Rosenberg, B. Walker, B. Walker, 1998, AIDS research and human retroviruses.

P09-09. Impact of immune-driven sequence variation in HIV-1 subtype C Gag-Protease on viral fitness and disease progression

B. Walker, T. Ndung’u, M. Brockman, 2009, Retrovirology.

HIV control through a single nucleotide on the HLA-I locus

B. Walker, T. Ndung’u, S. Buus, 2012, Retrovirology.

Oral abstracts of the 21st International AIDS Conference 18–22 July 2016, Durban, South Africa

Michael I. Jordan, Donald A. Jackson, J. G. Ndirangu, 2016, Journal of the International AIDS Society.

HIV type 1-specific cytotoxic T lymphocytes stimulate HLA class I and intercellular adhesion molecule type 1 expression and increase beta 2-microglobulin levels in vitro.

B. Walker, M. Heinkelein, C. Jassoy, 1994, AIDS research and human retroviruses.

Antiretroviral resistance during successful therapy of HIV type 1 infection.

E. Rosenberg, R. Siliciano, B. Walker, 2000, Proceedings of the National Academy of Sciences of the United States of America.

Hydroxyurea and didanosine long-term treatment prevents HIV breakthrough and normalizes immune parameters.

J. Lisziewicz, E. Rosenberg, J. Lieberman, 1999, AIDS research and human retroviruses.

Treatment of human immunodeficiency virus infection with hydroxyurea, didanosine, and a protease inhibitor before seroconversion is associated with normalized immune parameters and limited viral reservoir.

J. Lisziewicz, E. Rosenberg, J. Lieberman, 1999, The Journal of infectious diseases.

Elite control of HIV infection: implications for vaccine design

B. Walker, B. Baker, Blaine L. Block, 2009, Expert opinion on biological therapy.

A high-dimensional immune monitoring model of HIV-1-specific CD8 T cell responses accurately identifies subjects achieving spontaneous viral control

B. Walker, L. Chibnik, F. Porichis, 2012, Retrovirology.

Infrequent recovery of HIV from but robust exogenous infection of activated CD4(+) T cells in HIV elite controllers.

B. Walker, F. Pereyra, T. Miura, 2010, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Gag-specific cellular immunity determines in vitro viral inhibition and in vivo virologic control following SIV challenges of vaccinated monkeys

B. Walker, H. Li, D. Barouch, 2012, Retrovirology.

HIV control through a single nucleotide on the HLA-I locus

B. Walker, M. Carrington, B. Walker, 2012, Journal of Virology.

Reduced antiretroviral drug susceptibility among patients with primary HIV infection.

E. Rosenberg, B. Walker, D. Richman, 1999, JAMA.

P09-20 LB. Ultra-deep sequencing of full-length HIV-1 genomes identifies rapid viral evolution during acute infection

E. Rosenberg, H. Jessen, B. Walker, 2009, Retrovirology.

A high-dimensional immune monitoring model of HIV-1-specific CD8 T cell responses accurately identifies subjects achieving spontaneous viral control

D. Heckerman, B. Walker, F. Pereyra, 2012, Retrovirology.

T cell receptor clonotypes modulate the protective effect of human leukocyte antigen class I alleles in HIV-1 infection

B. Walker, F. Pereyra, T. Miura, 2012, Retrovirology.